The influence of cefepime on opsonophagocytosis of bacteria
- PMID: 2673713
The influence of cefepime on opsonophagocytosis of bacteria
Abstract
The effect of subminimal inhibitory concentrations (sub-MICs) of a semi-synthetic beta-lactam antibiotic, cefepime (BMY 28142), was studied on the opsonophagocytosis by human polymorphonuclear leukocytes (PNMs) of strains of Escherichia coli, Klebsiella oxytoca and Staphylococcus aureus. Cefepime-treated Gram-negative bacteria were not better phagocytosed by PMNs; however the uptake of one of three S. aureus strains was enhanced. The effect of cefepime on the uptake of strains of E. coli was compared to that of two other beta-lactam antibiotics, mecillinam and ceftriaxone. Exposure of E. coli to sub-MICs of mecillinam and ceftriaxone enhanced phagocytosis by PMNs.
Similar articles
-
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).Diagn Microbiol Infect Dis. 2007 Jan;57(1):109-16. doi: 10.1016/j.diagmicrobio.2006.06.011. Epub 2006 Aug 23. Diagn Microbiol Infect Dis. 2007. PMID: 16930923
-
Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface.Antimicrob Agents Chemother. 1990 Feb;34(2):332-6. doi: 10.1128/AAC.34.2.332. Antimicrob Agents Chemother. 1990. PMID: 2109580 Free PMC article.
-
Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.J Antimicrob Chemother. 2000 Sep;46 Suppl 1:9-14; discussion 63-5. J Antimicrob Chemother. 2000. PMID: 11051618
-
Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes.Zentralbl Bakteriol. 1991 Jan;274(4):519-26. doi: 10.1016/s0934-8840(11)80090-3. Zentralbl Bakteriol. 1991. PMID: 1907453
-
Specific and non-specific opsonins.Curr Top Microbiol Immunol. 1970;51:63-78. doi: 10.1007/978-3-642-46213-9_3. Curr Top Microbiol Immunol. 1970. PMID: 4914842 Review. No abstract available.
Cited by
-
Cefepime clinical pharmacokinetics.Clin Pharmacokinet. 1993 Aug;25(2):88-102. doi: 10.2165/00003088-199325020-00002. Clin Pharmacokinet. 1993. PMID: 8403741 Review.
-
Cefepime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs. 1994 Mar;47(3):471-505. doi: 10.2165/00003495-199447030-00007. Drugs. 1994. PMID: 7514976 Review.